6 Results for "

hPSCs

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "hPSCs" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-K1043

MCE CEPT Cocktail is composed of CET small molecules (Chroman 1, Emricasan and Trans-ISRIB) and Polyamine Solution, and can effectively enhance cell survival and promote clonal growth of genetically stable hPSCs.


loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13815
CAS No.: 1118807-13-8
Purity:  99.23%
Target:  

Wnt

Research Areas:  

Cardiovascular Disease

KY02111 is a canonical WNT signaling (β-catenin) inhibitor which promotes differentiation of hPSCs to cardiomyocytes. KY02111 can be used for the research of human cardiomyocyte regeneration .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-111630
CAS No.: 56563-17-8
Purity:  ≥98.0%
Target:  

Topoisomerase

Research Areas:  

Cancer

PluriSIn #2 is a selective transcriptional inhibitor of topoisomerase II α (TOP2A). PluriSIn #2 is a compound that selectively eliminates undifferentiated human pluripotent stem cells (hPSCs) .
loading...
    loading...
Cat. No.: HY-128020
CAS No.: 866149-26-0
Target:  

Phospholipase

Research Areas:  

Neurological Disease Cancer

ML114 is a specific inhibitor of RBBP9 serine hydrolase, with an IC50 of 0.63 μM against recombinant RBBP9. ML114 can inhibit the proliferation of human pluripotent stem cells (hPSCs) by regulating the expression of NFYA and other factors, but does not induce differentiation. ML114 can be used in the research of diseases such as retinoblastoma .
loading...
    loading...
Cat. No.: HY-111630R
CAS No.: 56563-17-8
Research Areas:  

Cancer

PluriSIn #2 (Standard) is the analytical standard of PluriSIn #2 (HY-111630). This product is intended for research and analytical applications. PluriSIn #2 is a selective transcriptional inhibitor of topoisomerase II α (TOP2A). PluriSIn #2 is a compound that selectively eliminates undifferentiated human pluripotent stem cells (hPSCs) .
loading...
    loading...
Cat. No.: HY-P12384
CAS No.: 287184-75-2
Research Areas:  

Inflammation/Immunology

GPQ-W is a synthetic peptide containing a type I collagen-derived protease cleavage site and serves as a protease-degradable crosslinker in PEG-4MAL/RGD synthetic hydrogels. GPQ-W is cleaved by cell-secreted matrix metalloproteinases, enabling cell-mediated matrix degradation and remodeling. GPQ-W, as a PEG-4MAL hydrogel component, supports the in vitro generation of human intestinal and lung organoids from hPSC-derived spheroids, long-term survival of intestinal organoids, normal epithelial cyst polarity, and lumen formation at the rapidly degrading crosslinker threshold level. GPQ-W can be used in research related to intestinal mucosal injury and organoid transplantation .
loading...
    loading...